CDX2 Expression Predicts Fluoropyrimidine Sensitivity Across Rare Non-GI Tumors: A Three-Case Series

Suleiman R, Garcia AD, Baral B, Halfdanarson TR, Fuentes Bayne HE.

DOI: 10.20944/preprints202601.1908.v1
Published: 2026-01-26
Container: Not recorded
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.20944/preprints202601.1908.v1,
  title = {CDX2 Expression Predicts Fluoropyrimidine Sensitivity Across Rare Non-GI Tumors: A Three-Case Series},
  author = {Suleiman R and  Garcia AD and  Baral B and  Halfdanarson TR and  Fuentes Bayne HE.},
  year = {2026},
  doi = {10.20944/preprints202601.1908.v1},
  url = {https://doi.org/10.20944/preprints202601.1908.v1}
}

RIS

TY  - JOUR
TI  - CDX2 Expression Predicts Fluoropyrimidine Sensitivity Across Rare Non-GI Tumors: A Three-Case Series
AU  - Suleiman R
AU  -  Garcia AD
AU  -  Baral B
AU  -  Halfdanarson TR
AU  -  Fuentes Bayne HE.
PY  - 2026
DO  - 10.20944/preprints202601.1908.v1
UR  - https://doi.org/10.20944/preprints202601.1908.v1
ER  -

APA

R, S., AD, G., B, B., TR, H., & HE., F. B. (2026). CDX2 Expression Predicts Fluoropyrimidine Sensitivity Across Rare Non-GI Tumors: A Three-Case Series. https://doi.org/10.20944/preprints202601.1908.v1

Source records

europe-pmc · retrieved 2026-09-24T22:10:46.336Z